Scientists Find New Gene Markers for Cancer Risk – Indiawest.comIndia WestProstate cancer is the second most common cancer in men after lung cancer, with about 900,000 new cases every year. Ovarian cancer accounts for about four percent of all cancers …
Dr. Gifford-Jones: Protecting yourself from acute kidney injury – Windsor Star (blog)
Dr. Gifford-Jones: Protecting yourself from acute kidney injuryWindsor Star (blog)A report from Johns Hopkins Hospital says that 20 million Americans suffer from chronic kidney disease. Kidney … According to Karl L. Womer, director of the Transplant …
Gilead Announces Response Data from Phase 2 Study of Idelalisib for … – Fort Mills Times
Gilead Announces Response Data from Phase 2 Study of Idelalisib for …Fort Mills TimesGilead Sciences, Inc. (Nasdaq: GILD) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigational, target…
Gilead Announces Response Data from Phase 2 Study of Idelalisib for … – MarketWatch (press release)
Gilead Announces Response Data from Phase 2 Study of Idelalisib for …MarketWatch (press release)Gilead Sciences, Inc. (NASDAQ:GILD) today announced results from a Phase 2 study (Study 101-08) evaluating idelalisib (formerly GS-1101), an investigation…
Civic body divided over iconic Mahalaxmi venue – Mumbai Mirror
Civic body divided over iconic Mahalaxmi venueMumbai MirrorThe 99-year lease agreement between the Royal Western India Turf Club (RWITC) and the BMC draws to an end this month, presenting an opportunity to the Shiv Sena, which is scouting for a memoria…
Heart failure patients living longer, but long-term survival still low – HealthCanal.com
|
Heart failure patients living longer, but long-term survival still low
HealthCanal.com BALTIMORE – People hospitalized for acute heart failure are likely to survive longer compared to the prior decade, according to a new study in the Journal of the American Heart Association and presented at the American Heart Association’s Quality of … |
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study – Xconomy
|
Genentech Cancer Antibody, Son of Rituxan, Nails Pivotal Study
Xconomy Genentech has been searching for years to find a way to improve upon rituximab (Rituxan), which set a gold standard 15 years ago as part of the first generation of targeted antibody cancer drugs. Now it looks like Genentech has finally nailed a new and … Roche Experimental Leukemia Drug Helps Shrink TumorsBloomberg Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease …Wall Street Journal (press release) |
MS Patient Gets Stem Cell Transplant – WTAJ
MS Patient Gets Stem Cell TransplantWTAJAs part of the procedure, she underwent chemotherapy and after that she started to regain mobility in her fingers and strength in her foot. On Tuesday May 14, she had the stem cell transplant and hopes that leads…
Scientists create embryonic stem cells from human skin – Times of India
 Times of India |
Scientists create embryonic stem cells from human skin
Times of India “A thorough examination of the stem cells derived through this technique demonstrated their ability to convert just like normal embryonic stem cells, into several different cell types, including nerve cells, liver cells and heart cells. Furthermore … US scientists in cloning breakthrough – The TelegraphCalcutta Telegraph |
The consolation of organ donation – Ottawa Citizen – Ottawa Citizen
 Regina Leader-Post |
The consolation of organ donation – Ottawa Citizen
Ottawa Citizen The primary motive for becoming an organ donor is to help someone else. One donor’s generosity can save the lives of up to seven people and improve the lives of up to 75 others. Our beloved daughter, Sarah Beth, died of sudden cardiac arrest at the … EGAN: Transplant hopefuls salute decision to donate teen’s organs – Leader PostRegina Leader-Post |